Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000021

President & CEO gave up 4,319 shares (to pay taxes)

  • President & CEO acquired 12,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hirsch Andrew · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-30 Exercise or conversion : show line 1 in the form +12,500 31,325 D
2023-01-30 Shares withheld for taxes : show line 2 in the form −4,319 $7.78 $33,602 27,006 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-30 Exercise or conversion : show line 3 in the form Performance Restricted Stock Units −12,500 62,500 D
Loading xslF345X03/wf-form4_167528577737212.xml…